LIFE SCIENCES — Innovatus Capital Partners

ABOUT STRATEGIES TEAM PORTFOLIO CURRENT OPENINGS

ABOUT INNOVATUS LIFE SCIENCES

Innovatus Capital Partners’ Life Sciences strategy (“Innovatus Life Sciences”) provides growth capital in the form of senior secured debt and equity to support innovative life science and technology companies. We are long term investors and our goal is to partner with established companies that are leaders in their field. We distinguish ourselves from other lenders by focusing on the dynamics of the business, including the strength of the product(s), the management team and access to liquidity. We seek to invest $20 to $100 million in public and private companies. We offer flexible and creative capital solutions that are tailored to the needs of our borrowers to achieve cash flow breakeven and/or a strategic exit.

The investment team has significant industry knowledge and has built a well-known market reputation over the last quarter century. Furthermore, we have a strong reputation for being more than just capital. Our strategic advice is well received by management teams and investors.

Innovatus is headquartered in New York City.

Representative Transactions¹

^{1 Representative transactions are shown for illustrative purposes only. For a complete list of transactions, please refer to our portfolios page.}